Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 20, Issue 7, Pages 1922-1924Publisher
WILEY
DOI: 10.1111/ajt.15920
Keywords
clinical research; practice; immunosuppressive regimens; infection and infectious agents-viral; kidney transplantation; nephrology
Categories
Ask authors/readers for more resources
The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
